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NAD (Nicotinamide Adenine Dinucleotide) biosynthesis is vital for bacterial physiology
and plays an important role in cellular metabolism. A naturally occurring vitamin B
complex, niacin (nicotinic acid), is a precursor of coenzymes NAD and NADP. Here, we
study the impact of niacin on global gene expression of Streptococcus pneumoniae
D39 and elucidate the role of NiaR as a transcriptional regulator of niaX, nadC, and
pnuC. Transcriptome comparison of the D39 wild-type grown in chemically defined
medium (CDM) with 0 to 10 mM niacin revealed elevated expression of various genes,
including niaX, nadC, pnuC, fba, rex, gapN, pncB, gap, adhE, and adhB2 that are
putatively involved in the transport and utilization of niacin. Niacin-dependent expression
of these genes is confirmed by promoter lacZ-fusion studies. Moreover, the role of
transcriptional regulator NiaR in the regulation of these genes is explored by DNA
microarray analysis. Our transcriptomic comparison of D39 1niaR to D39 wild-type
revealed that the transcriptional regulator NiaR acts as a transcriptional repressor
of niaX, pnuC, and nadC. NiaR-dependent regulation of niaX, nadC, and pnuC is
further confirmed by promoter lacZ-fusion studies. The putative operator site of NiaR
(5′-TACWRGTGTMTWKACASYTRWAW-3′) in the promoter regions of niaX, nadC, and
pnuC is predicted and further confirmed by promoter mutational experiments.
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INTRODUCTION
Bacteria can trigger transcriptional and phenotypic programs to synchronize an adaptive response
in reaction to environmental fluctuations or stresses (Edwards et al., 2013). This not only relies
on the number of virulence factors it possesses, but also on the proper use of nutrients available
in the human niches (Phillips et al., 1990; Titgemeyer and Hillen, 2002). A number of important
vitamins and co-factors are required by bacteria to survive and grow successfully. Streptococcus
pneumoniae, a major Gram-positive human pathogen and nasopharyngeal colonizer, encounters
different environmental factors and has to fine-tune its gene expression accordingly (Bogaert et al.,
2004; Kadioglu et al., 2008).
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Niacin (nicotinic acid), a naturally occurring vitamin B
complex, is a precursor of coenzymes NAD and NADP, and plays
an important role in electron transfer during metabolic processes
(Wei et al., 2014). Niacin has long been used for the treatment
of lipid disorders and cardiovascular disease (Wei et al., 2014).
It can regulate the activity of microbial two-component systems
and, subsequently, modulate the genes and phenotypes that are
controlled by these regulatory proteins (McPheat et al., 1983).
Particularly, niacin has been reported to repress the expression
of many genes including virulence factors in Bordetella pertussis,
such as pertussis toxin, adenylate cyclase toxin, and filamentous
hemagglutinin (Schneider and Parker, 1982; McPheat et al., 1983;
Cotter and DiRita, 2000; Cummings et al., 2006). Furthermore,
the two-component system BvgA/BvgS, which is known to have
a role in the regulation of virulence and colonization, becomes
inactive in B. pertussis when niacin is present in the medium
(Miller et al., 1989). Similarly, the Escherichia coli EvgA/EvgS
system that confers multidrug resistance and acid tolerance is
regulated by niacin (Masuda and Church, 2002, 2003; Eguchi
et al., 2003; Nishino et al., 2003). Both the BvgA/BvgS system of B.
pertussis and the EvgA/EvgS system of E. coli are part of a family
of proteins that utilize a multistep phosphor-relay to trigger their
responsive pathways.
It has been proposed that in S. pneumoniae niacin enters
the cell through NiaX and is converted to nicotinate (nicotinic
acid)-mononucleotide by PncB (Johnson et al., 2015). Nicotinate
mononucleotide is then converted to nicotinic acid adenine
dinucleotide by NadD, whereafter NadE converts nicotinic
acid adenine dinucleotide to nicotine adenine dinucleotide
(NAD) (Johnson et al., 2015). Another important enzyme
glyceraldehyde-3-phosphate dehydrogenase (GAP) is a highly
conserved and a multifunctional protein with significant activity
in several fundamental cell pathways (Sirover, 2011). Usually,
the dehydrogenase reactions of metabolic pathways have
been deemed the major sources of NADPH. Nevertheless, the
importance of transhydrogenases, glucose dehydrogenases,
and non-phosphorylating glyceraldehyde 3- phosphate
dehydrogenase (GAPN), is becoming eminent, suggesting
that the traditional view is over-simplistic (Sauer U. et al., 2004;
Matsubara et al., 2011; Bräsen et al., 2014). As NAD is a vital
cofactor used by all living organisms, all bacterial species make
use of the pathways to reduce NAD+ to NADH (Jurtshuk, 1996).
NAD+ is also used by bacteria as a substrate for dehydrogenases
involved in breaking down aldehydes and alcohols (Nobelmann
and Lengeler, 1996; Kotrbova-Kozak et al., 2007; Luong et al.,
2015). Furthermore, several cellular processes in bacterial and
mammalian cells also use NAD, for instance DNA ligation and
repair, redox recycling in the pyruvate dehydrogenase pathway,
and synthesis of acetyl-CoA for the tricarboxylic acid cycle
(Ishino et al., 1986; Satoh and Lindahl, 1992; Wilkinson et al.,
2001; Chalkiadaki and Guarente, 2012; Chiarugi et al., 2012;
Patel et al., 2014).
YrxA (NiaR) was found to be a niacin-responsive repressor
of NAD de novo synthesis in Bacillus subtilis and transcriptional
regulation of NAD biosynthesis in bacteria having orthologs
of B. subtilis yrxA was determined using a comparative
genomic approach and expression studies (Rodionov et al.,
2008a). NiaR family members are generally conserved in the
Bacillus/Clostridium group and in the unrelated Fusobacteria
and Thermotogales lineages (Rodionov et al., 2008a). The NiaR
regulon is not limited to the transcriptional regulation of the
nadABC but in some species it also covers niacin salvage
(the pncAB genes) and contains uncharacterized membrane
proteins putatively involved in niacin transport (Rodionov et al.,
2008a). Moreover, members of the NiaP family (involved in
niacin uptake) are not only conserved in bacteria but also
in multicellular eukaryotes, including humans, suggesting the
putative involvement of NiaP in niacin utilization in these
organisms (Rodionov et al., 2008a).
This study explains the transcriptomic response of S.
pneumoniae D39 to niacin and regulation of niaX, pnuC, and
nadC genes. We established that the transcriptional regulator
NiaR acts as a transcriptional repressor for niaX, pnuC, and nadC
genes involved in niacin uptake and utilization. The putative
operator site (5′-TACWRGTGTMTWKACASYTRWAW-3′
where R= A/G, K=G/T, S=G/C, Y= T/C, W= A/T and M=
A/C) of NiaR in the promoter regions of niaX, pnuC, and nadC
is predicted, and subsequently confirmed by mutating NiaR
operator sites in the respective promoters.
MATERIALS AND METHODS
Bacterial Strains and Growth Conditions
Bacterial strains and plasmids used in this study are listed
in Table 1. S. pneumoniae D39 was grown as described
previously (Kloosterman et al., 2006; Afzal et al., 2014). For
β-galactosidase assays, derivatives of S. pneumoniae D39 were
grown in chemically defined medium (CDM) (Neves et al., 2002)
with or without 10 mM niacin. CDM was prepared without
niacin. For selection on antibiotics, media were supplemented
with the following concentrations of antibiotics: 150 µg/ml
spectinomycin and 2.5µg/ml tetracycline for S. pneumoniae, and
100 µg/ml ampicillin for E. coli. All bacterial strains used in
this study were stored in 10% (v/v) glycerol at −80◦C. For PCR
amplification, chromosomal DNA of S. pneumoniae D39 (Lanie
et al., 2007) was used as a template. Primers used in this study
are based on the sequence of the S. pneumoniaeD39 genome and
listed in Table 2.
Construction of a niaR Mutant
A niaR mutant (MA1300) was constructed in S. pneumoniae
D39 by allelic replacement with a spectinomycin-resistance
cassette. Primer pairs niaR-1/niaR-2 and niaR-3/niaR-4
were used to generate PCR fragments of the left and right
flanking regions of niaR using Phusion R© High-Fidelity
DNA polymerase. PCR products of left and right flanking
regions of niaR contain AscI and NotI sites, respectively.
The spectinomycin-resistance marker, which was amplified
by primers SpecR/SpecF from pORI38, also contains AscI
and NotI sites on its ends. Then, by restriction and ligation,
the left and right flanking regions of niaR were fused to the
spectinomycin-resistance gene. The resulting ligation products
were transformed to S. pneumoniae D39 wild-type and selection
of the mutant was done on the appropriate concentration
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of spectinomycin. Deletion of niaR was further verified by
PCR using primer pair NiaR-Conf-1/NiaR-Conf-2 and DNA
sequencing.
Construction of Promoter lacZ-fusions and
Their Use in β-Galactosidase Assays
Chromosomal transcriptional lacZ-fusions to niaX, pnuC, and
nadC promoters were constructed in pPP2 (Halfmann et al.,
2007) with primer pairs mentioned in Table 2, resulting
in pMA1301-03, respectively. These constructs were further
introduced into D39 wild-type and D39 1niaR (MA1300)
resulting in strains MA1301-03 and MA1304-06, respectively.
The following lacZ-fusions of PniaX, PpnuC, and PnadC with
mutations in the NiaR site were made in pPP2 (Halfmann
et al., 2007) using the primer pairs mentioned in Table 2:
PniaX-M (mutation in the niaR site), PpnuC-M (mutation
in the niaR site), PnadC-R1 (mutation in the niaR site 1),
and PnadC-R2 (mutation in the niaR site 2), resulting in
plasmids pMA1304-07, respectively. These constructs were
introduced into the S. pneumoniaeD39wild-type strain, resulting
in strains MA1307-1310, respectively. Similarly, chromosomal
transcriptional lacZ-fusions to fba, rex, gapN, pncB, gap, adhE,
and adhB2 promoters were constructed in pPP2 (Halfmann
et al., 2007) with primer pairs mentioned in Table 2, resulting
in pMA1308-14, respectively. These constructs were further
introduced into D39 wild-type resulting in strains MA1311-
17, respectively. All plasmid constructs were further checked
for the presence of the right insert by PCR and DNA
sequencing.
β-galactosidase assays were performed as described before
(Israelsen et al., 1995; Halfmann et al., 2007) using cells that were
harvested in the mid-exponential growth phase, and grown in
CDM (Neves et al., 2002) with or without niacin as mentioned
in the results section.
Microarray Analysis
Microarray analysis was performed as described before (Afzal
et al., 2015; Shafeeq et al., 2015). For DNA microarray analysis
of S. pneumoniae in the presence of niacin, the transcriptome of
S. pneumoniae D39 wild-type grown in replicates in CDM with
10mM niacin was compared to that grown in CDM with 0 mM
niacin and harvested at their respective mid-exponential growth
phases.
For DNA microarray analysis of D39 1niaR, the
transcriptome of S. pneumoniae D39 1niaR was compared
to S. pneumoniae D39 wild-type grown in replicates in
complete CDM and harvested at respective mid-exponential
growth phases. Complete CDM contains 8 µM of niacin.
The procedures for DNA microarray analysis were performed
as described previously (Afzal et al., 2015; Shafeeq et al.,
2015). For the identification of differentially expressed genes,
a Bayesian p < 0.001 and a fold-change cut-off > 1.5 was
applied. Microarray data have been submitted to GEO (Gene
Expression Omnibus) under accession numbers GSE94511 and
GSE94513.
TABLE 1 | List of strains and plasmids used in this study.
Strain/plasmid Description Source
S. PNEUMONIAE
D39 Serotype 2 strain. cps 2 Laboratory of P. Hermans.
MA1300 D39 1niaR; SpecR This study
MA1301 D39 1bgaA:: PniaX-lacZ; TetR This study
MA1302 D39 1bgaA:: PpnuC-lacZ; TetR This study
MA1303 D39 1bgaA:: PnadC-lacZ; TetR This study
MA1304 MA1300 1bgaA:: PniaX-lacZ; TetR This study
MA1305 MA1300 1bgaA:: PpnuC-lacZ;
TetR
This study
MA1306 MA1300 1bgaA:: PnadC-lacZ;
TetR
This study
MA1307 D39 1bgaA:: PniaX-M-lacZ; TetR This study
MA1308 D39 1bgaA:: PnuC-M-lacZ; TetR This study
MA1309 D39 1bgaA:: PnadC-R1-M-lacZ;
TetR
This study
MA1310 D39 1bgaA:: PnadC-R2-M-lacZ;
TetR
This study
MA1311 D39 1bgaA:: Pfba-lacZ; TetR This study
MA1312 D39 1bgaA:: Prex-lacZ; TetR This study
MA1313 D39 1bgaA:: PgapN-lacZ; TetR This study
MA1314 D39 1bgaA:: PpncB-lacZ; TetR This study
MA1315 D39 1bgaA:: Pgap-lacZ; TetR This study
MA1316 D39 1bgaA:: PadhE-lacZ; TetR This study
MA1317 D39 1bgaA:: PadhB2-lacZ; TetR This study
E. COLI
EC1000 KmR; MC1000 derivative carrying
a single copy of the pWV1 repA
gene in glgB
Laboratory collection
PLASMIDS
pPP2 AmpR TetR; promoter-less lacZ.
For replacement of bgaA with
promoter lacZ fusion. Derivative of
pPP1
Halfmann et al., 2007
pMA1301 pPP2 PniaX-lacZ This study
pMA1302 pPP2 PpnuC-lacZ This study
pMA1303 pPP2 PnadC-lacZ This study
pMA1304 pPP2 PniaX-M-lacZ This study
pMA1305 pPP2 PnuC-M-lacZ This study
pMA1306 pPP2 PnadC-R1-M-lacZ This study
pMA1307 pPP2 PnadC-R1-M-lacZ This study
pMA1308 pPP2 Pfba-lacZ This study
pMA1309 pPP2 Prex-lacZ This study
pMA1310 pPP2 PgapN-lacZ This study
pMA1311 pPP2 PpncB-lacZ This study
pMA1312 pPP2 Pgap-lacZ This study
pMA1313 pPP2 PadhE-lacZ This study
pMA1314 pPP2 PadhB2-lacZ This study
RESULTS
Niacin-dependent Gene Regulation in S.
pneumoniae D39
Microarray comparison of S. pneumoniae D39 grown in CDM
with 0 mM to same strain grown in CDM with 10mM
niacin was performed to explore the impact of niacin on
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TABLE 2 | List of primers used in this study.
Name Nucleotide Sequence (5′ →3′) Restriction site*
niaX-F CATGGAATTCTCAAACCTGAAGGTGGAGAT EcoRI
niaX-R CATGGGATCCGCATAACAATTGGAATCAAAATCG BamHI
pnuC-F CATGGAATTCCCATATGATTCTTTCTAATGAGTTG EcoRI
pnuC-R CATGGGATCCGCAAATAAGTATGCATCATTTCTCC BamHI
nadC-F CATGGAATTCCCAATGGCTAGAGCAATGGC EcoRI
nadC-R CATGGGATCCCATCTTCTCGCAAGGCTGC BamHI
niaX-M-R CATGGGATCCCACAAGAATCTCCTTTTTAACGGCATATGTACTAGTATGG BamHI
pnuC-M-F CATGGAATTCCATGATTTTCTAAAATTTTACTACAAAGACGGTTGAC EcoRI
nadC-R1-M-F CATGGAATTCGACTATTATACACAAAAAAAATACAATTACCTTGACCATTGTA EcoRI
nadC-R2-M-F CATGGAATTCTACACAAAAAAAATACAATTGTCTTGACAATTACATTGACCCTTGTT EcoRI
NiaR-1 GCCATGTTCTTGTCGCCC -
NiaR-2 GCATAGGCGCGCCCAAGAGTTGGAGCAGGGC AscI
NiaR-3 CGATTGCGGCCGCGCCGAAACACAACAAGACC NotI
NiaR-4 CGCTGGTCTGGTTATGCC -
fba-F CATGGAATTCCGTCCAAGACTAGGGAGAG EcoRI
fba-R CATGGGATCCGCATAACCGTTGTCACGGG BamHI
rex-F CATGGAATTCCCTCATGGATAGCTTGGTAG EcoRI
rex-R CATGGGATCCGCTGTAGCTTTTGGAATAGC BamHI
gapN-F CATGGAATTCGGTTTGGCTGTCCCCAACC EcoRI
gapN-R CATGGGATCCGTCATGGCTGGAACTGTACC BamHI
pncB-F CATGGAATTCGCTATGGCGAATGGGCTC EcoRI
pncB-R CATGGGATCCCTGGTACAAGTCCGTGTGC BamHI
gap-F CATGGAATTCCGTTACGCTATGAATAATAAGGG EcoRI
gap-R CATGGGATCCCGACCGATACGTCCGAAACC BamHI
adhE-F CATGGAATTCGCGCTTACCTGTAAATCCC EcoRI
adhE-R CATGGGATCCGAACCAACTCATCTACGTGC BamHI
adhB2-F CATGGAATTCGCAACCTACCTAGATGGCG EcoRI
adhB2-R CATGGGATCCGCACAATAGCGTCTGTTGGC BamHI
NiaR-Conf-1 GGAGATTCTTGTGAATACACGG -
NiaR-Conf-2 GATAATATCTCTGGTAGTAAGTCTG -
Spec-R GCTAAGCGGCCGCACTAAACGAAATAAACGC NotI
Spec-F GCTATGGCGCGCCCTAATCAAAATAGTGAGGAGG AscI
*Restriction sites are underlined.
the transcriptome of S. pneumoniae D39 wild-type. CDM was
prepared without niacin. A number of genes/operons were
differentially expressed under our tested conditions (Table 3).
A particular gene cluster (spd-0093-0095) was significantly
upregulated in the absence of niacin. This gene cluster
codes for three hypothetical proteins, which are putative
membrane proteins. Another gene cluster (spd-1798-1802)
was significantly upregulated in the absence of niacin. This
gene cluster consists of a DNA-binding response regulator
(encoded by spd-1798), a sensor histidine kinase (encoded
by spd-1799), two hypothetical proteins (encoded by spd-
1800 and spd-1802) and an ABC transporter (encoded by
spd-1801). Some genes that appear to be a part of a gene
cluster were also downregulated under our tested conditions
(spd-0113-15 and spd-0122-24). All of these genes code for
hypothetical proteins and the role of these genes warrants further
investigation.
Putative niacin biosynthesis pathway genes were significantly
upregulated in the absence of niacin (fba, rex, gapN, niaX,
pncB-nadE, pnuC, gap, spd-1824, nadC, adhE, and adhB2).
fba codes for a fructose-bisphosphate aldolase, whereas rex
encodes a redox-sensitive transcriptional regulator. Similarly,
gapN encodes a glyceraldehyde-3-phosphate dehydrogenase
that is involved in generation of NADPH from NADH.
pncB encodes a nicotinate phosphoribosyltransferase that
converts nicotinate into nicotinate D-ribonucleotide and
vice versa, whereas nadE encodes a NAD+ synthetase
that converts deamino-NAD+ to NAD+ and adhE codes
for an alcohol dehydrogenase. gap encodes another
glyceraldehyde-3-phosphate dehydrogenase and adhE codes
for an iron-containing alcohol dehydrogenase, whereas
adhB2 encodes a zinc-containing alcohol dehydrogenase.
NiaX (encoded by niaX) is a substrate-specific component
predicted niacin ECF transporter, whereas PnuC (encoded by
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TABLE 3 | Summary of the transcriptome comparison of S. pneumoniae
D39 wild-type grown in CDM with 0mM niacin to grown in CDM with
10mM niacin.
D39 taga Functionb Ratioc
UPREGULATED GENES
spd_0093 Hypothetical protein 3.1
spd_0094 Hypothetical protein 2.8
spd_0095 Hypothetical protein 2.4
spd_0474 Hypothetical protein 4.6
spd_0475 CAAX amino terminal protease family
protein
3.5
spd_0526 Fructose-1,6-bisphosphate aldolase,
class II, Fba
1.5
spd_0976 Redox-sensitive transcriptional
regulator Rex
1.5
spd_1004 Glyceraldehyde-3-phosphate
dehydrogenase, NADP-dependent,
GapN
3.5
spd_1091 Substrate-specific component
predicted niacin ECF transporter, NiaX
1.8
spd_1250 NAD+ synthetase, NadE 1.5
spd_1251 Nicotinate phosphoribosyltransferase,
putative, PncB
1.9
spd_1640 Ribosyl nicotinamide transporter,
PnuC-like, PnuC
4.2
spd_1798 DNA-binding response regulator 2.1
spd_1799 Sensor histidine kinase, putative 2.0
spd_1800 Hypothetical protein 2.4
spd_1801 ABC transporter, ATP-binding protein 2.0
spd_1802 Hypothetical protein 2.2
spd_1823 Glyceraldehyde-3-phosphate
dehydrogenase, type I, Gap
1.7
spd_1824 Hypothetical protein 2.2
spd_1826 Nicotinate-nucleotide
pyrophosphorylase, NadC
4.4
spd_1827 Hypothetical protein 3.1
spd_1833 PTS system, IIA component 1.7
spd_1834 Alcohol dehydrogenase,
iron-containing, AdhE
5.8
spd_1865 Alcohol dehydrogenase,
zinc-containing, AdhB2
1.7
spd_1874 LysM domain protein 3.7
DOWNREGULATED GENES
spd_0113 Hypothetical protein −2.9
spd_0114 Hypothetical protein −3.1
spd_0115 Hypothetical protein −2.7
spd_0122 Hypothetical protein −2.2
spd_0123 Hypothetical protein −2.4
spd_0124 Hypothetical protein −2.0
aGene numbers refer to D39 locus tags.
bD39 annotation/TIGR4 annotation (Lanie et al., 2007).
cRatio represents the fold increase/decrease in the expression of genes in CDM with 0
mM Niacin to CDM with 10 mM Niacin. Errors in the ratios never exceeded 10% of the
given values.
pnuC) is a ribosyl nicotinamide transporter. NadC (encoded
by nadC) is a nicotinate-nucleotide pyrophosphorylase
and has been proposed to convert quinolinate formed
TABLE 4 | Summary of transcriptome comparison of S. pneumoniae D39
1niaR compared to the D39 wild-type grown in complete CDM.
D39 taga Functionb Ratioc
spd_1091 Substrate-specific component predicted niacin
ECF transporter, NiaX
2.1
spd_1093 Transcriptional regulator, biotin repressor family
protein, NiaR
−2.7
spd_1640 Ribosyl nicotinamide transporter, PnuC-like,
PnuC
1.5
spd_1824 Hypothetical protein 3.5
spd_1826 Nicotinate-nucleotide pyrophosphorylase,
NadC
7.2
spd_1827 Hypothetical protein 3.1
Complete CDM contains 8 µM of niacin.
aGene numbers refer to D39 locus tags.
bD39 annotation/TIGR4 annotation (Lanie et al., 2007).
cRatio represents the fold increase/decrease in the expression of genes in D39 ∆niaR
compared to the D39 wild-type in complete CDM. Errors in the ratios never exceeded
10% of the given values.
from alanine, aspartate, and glutamate, and tryptophan
metabolism into nicotinate D-ribonucleotide (Kanehisa et al.,
2014).
Niacin-dependent Expression of fba, rex,
gapN, niaX, pncB, pnuC, gap, spd-1824,
nadC, adhE, and adhB2
Our niacin-dependent microarray data mentioned above
indicated the role of niacin in the regulation of fba, rex, gapN,
niaX, pncB, pnuC, gap, spd-1824, nadC, adhE, and adhB2. To
confirm our microarray results and further study the effect
of niacin on the expression of fba, rex, gapN, niaX, pncB,
pnuC, gap, spd-1824, nadC, adhE, and adhB2, we performed
β-galactosidase assays with promoter lacZ-fusions of these
genes constructed in S. pneumoniae D39 wild-type. Our β-
galactosidase data demonstrated that the expression of Pfba-lacZ,
Prex-lacZ, PgapN-lacZ, PniaX-lacZ, PpncB-lacZ, PpnuC-lacZ,
Pgap-lacZ, PnadC-lacZ, PadhE-lacZ, and PadhB2-lacZ increased
significantly in the absence of niacin in the medium (Figure 1).
These data further confirm our microarray data described above
and suggest the role of niacin in the regulation of these genes.
Microarray Analysis of D39 1niaR
Niacin genes are mostly regulated by a transcriptional regulator
NiaR in different bacteria (Novichkov et al., 2010). In Firmicutes
and Thermotogales, transcriptional regulator NiaR regulates the
NAD biosynthesis and salvage of niacin (Rodionov et al., 2008a).
NiaR was first studied in B. subtilis as a niacin-responsive
transcriptional repressor that binds to its DNA targets in the
presence of niacin (Rossolillo et al., 2005). NiaR belongs to
a unique protein family, which possesses an N-terminal HTH
(Helix-Turn-Helix) DNA binding domain (PF08279) and a
C-terminal effector binding domain, called the 3H domain
(PF02829). S. pneumoniae also possesses a NiaR transcriptional
regulator, which might be involved in the regulation of the
niacin-regulated genes described above. Therefore, we decided to
further study the role of NiaR in the regulation of these genes.
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FIGURE 1 | Expression levels (in Miller units) of PniaX-lacZ, PpnuC-lacZ, PnadC-lacZ, Pfba-lacZ, Prex-lacZ, PpncB-lacZ, Pgap-lacZ, PadhE-lacZ,
PadhB2-lacZ, and PgapN-lacZ in CDM with 0 and 10 mM niacin in S. pneumoniae D39 wild-type. Standard deviations of three independent experiments are
indicated in bars. Statistical significance of the differences in the expression levels was determined by one-way ANOVA (NS, not significant, **P < 0.001, and ***P <
0.0001).
FIGURE 2 | Expression levels (in Miller units) of PniaX-lacZ,
PpnuC-lacZ, and PnadC-lacZ in complete CDM in S. pneumoniae D39
wild-type and D39 1niaR. Standard deviations of three independent
experiments are indicated in bars. Statistical significance of the differences in
the expression levels was determined by one-way ANOVA (NS, not significant,
**P < 0.001, and ***P < 0.0001).
A deletion mutant of the niaR gene was constructed
and microarray comparison of S. pneumoniae D39
1niaR to D39 wild-type grown in complete CDM was
performed to investigate the role of NiaR in S. pneumoniae
D39. Complete CDM contains 8 µM of niacin. Table 4
summarizes the transcriptome changes induced by the
deletion of niaR in S. pneumoniae D39. Expression of
niaR was downregulated about 3-fold confirming the
niaR deletion in D39 1niaR. Expression of nadC, niaX,
and pnuC was upregulated significantly in D39 1niaR,
suggesting the role of NiaR as a transcriptional repressor of
niaX, nadC, and pnuC in S. pneumoniae D39. Expression
of spd-1824 and spd-1827 (coding for hypothetical
proteins) was also upregulated. Spd-1827 is localized
adjacent to nadC (spd-1826), but transcribed in opposite
direction.
Role of NiaR as a Transcriptional
Repressor of niaX, nadC, and pnuC
To further investigate the role of NiaR in the regulation of
niaX, nadC, and pnuC, we transformed the lacZ-fusions of
the promoter regions of niaX, nadC, and pnuC into D39
1niaR and performed β-galactosidase assays in complete CDM
(Figure 2). The results of the β-galactosidase assays showed
that the activity of all these promoters increased significantly
in D39 1niaR compared to the D39 wild-type, confirming the
role of NiaR as a transcriptional repressor of niaX, nadC, and
pnuC.
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FIGURE 3 | Organization of the NiaR-regulated genes in S. pneumoniae D39. Putative NiaR operator sequences are rectangle and translational initiation sites
are italicized, whereas the lollipop structures represent the putative transcriptional terminators. See text for further details.
Prediction and Confirmation of the NiaR
Site in PniaX, PnadC, and PpnuC
The promoter regions of all of the upregulated genes, including
spd_1824 and spd_1827, were analyzed by Genome2D software
(Baerends et al., 2004) and a MEME motif sampler search
(Bailey and Elkan, 1994). A 22-bp palindromic-like sequence
was found in the promoter regions of niaX, nadC, and pnuC
(Figure 3). This DNA sequence might serve as the NiaR operator
site in S. pneumoniae. PniaX from different streptococci was
also analyzed for the presence of NaiR site. The NiaR site
present in the promoter region of niaX of different streptococci
is shown in Figure 4. Weight matrix based on these putative
NiaR sites (5′- TACWRGTGTMTWKACASYTRWAW -3′) was
constructed (Figure 4).
The predicted NiaR operator site present in the promoter
regions of niaX, nadC, and pnuC was further verified by
promoter mutational experiment. For this purpose, we made
transcriptional lacZ-fusions of PniaX, PpnuC, and PnadC, where
conserved bases in the putative NiaR sites were mutated in PniaX
(5′- TACTAGTGTATATGCAGTTAAA-3′ to 5′- TACTAG
TACATATGCCGTTAAA -3′), PpnuC (5′- TTTTACTGTAAA
GACAGTTGAC -3′ to 5′- TTTTACTACAAAGACGGTTGAC
-3′), PnadC-R1 (5′- TACAATTGTCTTGACAATTGTA -3′ to
5′- TACAATTACCTTGACCATTGTA -3′), and PnadC-R2 (5′-
GACAATTGTATTGACACTTGTT -3′ to 5′- GACAATTACAT
TGACCCTTGTT -3′). β-galactosidase assays were performed on
cells grown in complete CDM. Complete CDM contains 8 µM
of niacin. The expression of PniaX and PpnuC with mutated
conserved bases of NiaR operator sites increased significantly in
S. pneumoniaeD39wild-type, confirming that the predictedNiaR
sites present in the promoter regions of niaX and pnuC are active
and intact in S. pneumoniae (Figure 5). Two putative operator
sites for NiaR are present in PnadC (R1 and R2). We mutated
both sites individually and performed β-galactosidase assays. We
could only observe derepression (caused by NiaR) in the activity
of PnadC when NiaR operator site 2 (R2) was mutated and did
not observe any change in the activity of PnadC due to mutation
in NiaR operator site 1 (R1) (Figure 5). These data suggest that
operator site 2 (R2) is the functional operator site in PnadC.
DISCUSSION
NAD is an essential cofactor used by all living organisms. NAD
synthesis is a tightly regulated intracellular process in bacteria
(Huang et al., 2009). Bacteria acquire NAD in two main ways:
through de novo synthesis and through the salvage pathway.
Some bacteria do not have the ability to de novo synthesize
NAD and must make use of the salvage pathway to import
niacin or nicotinamide riboside through the substrate importers
NiaX and PnuC, respectively. The de novo pathway synthesizes
NAD from aspartic acid, whereas the salvage pathway brings
intermediates many steps downstream into the NAD de novo
synthesis pathway (Rodionov et al., 2008b). NiaX and PnuC are
the two major importers in the NAD salvage pathway, where
NiaX is responsible for niacin uptake, and PnuC transports
nicotinamide riboside (Herbert et al., 2003; Sauer E. et al., 2004;
Rodionov et al., 2008a, 2009). Our current study demonstrates
the transcriptomic response of S. pneumoniae to niacin and
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FIGURE 4 | Identification of the NiaR operator site. (A) Weight matrix of the identified NiaR operator site in the promoter regions of niaX, nadC, and pnuC. (B)
Position of the NiaR operator site in the promoter region of niaX, nadC, and pnuC in different streptococci. Putative NiaR operator sites are bold and underlined. SP, S.
pneumoniae; SI, Streptococcus mitis; SA, Streptococcus agalactiae; SD, Streptococcus dysgalactiae; SE, Streptococcus equi; SG, Streptococcus gallolyticus; SN,
Streptococcus gordonii; SM, Streptococcus mutans; SO, Streptococcus pyogenes; SS, Streptococcus sanguinis; SU, Streptococcus suis; ST, Streptococcus
thermophiles; and SB, Streptococcus uberis.
reveals that a number of genes including pnuC, pncB, and nadC
are differentially expressed under the tested conditions. We
further demonstrate that a transcriptional regulator NiaR acts
as a transcriptional repressor of niaX, pnuC, and nadC in the
presence of niacin.
An extracellular protein capable of modifying nicotinamide
mononucleotide to an importable form appears to help NiaX
and PnuC for importing nicotinamide mononucleotide or there
may be another import system in S. pneumoniae (Johnson
et al., 2015). There is significant variability between PnuC
homologs (Jaehme et al., 2014), and the PnuC homologs from
Haemophilus influenzae and Salmonella typhimurium do not
import nicotinamide mononucleotide, but can transform it to
an importable form for PnuC (nicotinamide riboside) through
NadN or AphA, respectively (Kemmer et al., 2001; Grose et al.,
2005). The PnuC proteins from H. influenzae, S. typhimurium,
and S. pneumoniae all possess the motif for nicotinamide
mononucleotide binding. Nevertheless, PnuC homologs from
many other organisms lack the consensus binding residues
(Kemmer et al., 2001; Sauer E. et al., 2004; Grose et al.,
2005). These observations indicate that different groups of
NAD salvage substrate importers (annotated as PnuC) import
nicotinamide riboside and/or nicotinamidemononucleotide, and
that NiaX imports niacin and/or nicotinamide mononucleotide
as preferred substrates. Moreover, the amino acids in Salmonella
PnuC curtailing import of nicotinamide mononucleotide are
not conserved in the pneumococci, suggesting that the
pneumococcal PnuC may permit this substrate along with
nicotinamide riboside. Although, both PnuC and NiaX in
S. pneumoniae may have acquired the ability to import
nicotinamide mononucleotide, an extra importer (that is yet to
be characterized) may also be present (Johnson et al., 2015). The
role of PnuC in pneumococcal pathogenesis has been studied
and PnuC could be a potential viable small molecule therapeutic
target to halt disease progression in the host (Johnson et al.,
2015). The proposed NAD pathway in S. pneumoniae states that
niacin and nicotinamide enter the cells through NiaX, and PnuC
transports nicotinamide riboside to the inside of the cell, whereas
the transporter for nicotinamide mononucleotide is unknown
(Johnson et al., 2015). spd-1411 encodes a nicotinamidase
(PncA) that converts nicotinamide into niacin, which is further
converted into nicotinate mononucleotide by a nicotinic acid
phosphoribosyltransferase (PncB) (Johnson et al., 2015). The
nicotinate mononucleotide is then converted into NAD by
NadD and NadE. Moreover, NadD (nicotinate/nicotinamide
nucleotide adenylyltransferase) converts nicotinamide riboside
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FIGURE 5 | Expression levels (in Miller units) of PniaX-lacZ,
PpnuC-lacZ, and PnadC-lacZ with mutated and non-mutated NiaR
operator sites in S. pneumoniae D39 wild-type grown in complete
CDM. Standard deviations of three independent experiments are indicated in
bars. Statistical significance of the differences in the expression levels was
determined by one-way ANOVA (NS, not significant, **P < 0.001, and ***P <
0.0001).
and nicotinamide mononucleotide into NAD (Johnson et al.,
2015). Nicotinamide riboside augmentation has been attributed
to several advantageous functions in the host, including shielding
against mitochondrial myopathy (Khan et al., 2014), hearing
loss (Brown et al., 2014) and obesity (Cantó et al., 2012). These
functions may not be due to increasing NAD synthesis (Frederick
et al., 2015), but may be due to overall bioavailability. While
nicotinamide riboside is required for pathogen and host, luckily
pneumococcal PnuC and its homologous in other bacteria do not
have sequence homology to any proteins in the animal kingdom.
Hence, PnuC could be a potential therapeutic target in bacterial
species shielding this pathway without mammalian significance
as has been effectively shown with H. influenzae (Sauer E. et al.,
2004).
NiaR orthologs have been found in 30 out of 45 species
from the Bacillus/Clostridium group (Firmicutes), in addition
to the diverged groups of the Fusobacteria and Thermotogales
and for the Bacillus/Clostrida group another DNA binding site
was proposed (Rodionov et al., 2008a). There are two different
types of DNA-binding sites of NiaR i.e., type I operator found in
Firmicutes and Fusobacteria, and type II in the Thermotogales.
The niacin-responsive transcription factor NiaR (known as YrxA
in B. subtilis) was first recognized as a nicotinic acid-responsive
repressor of the de novo NAD biosynthesis operon (nadABC)
in B. subtilis (Rossolillo et al., 2005). NiaR regulation of the
niacin salvage genes pncB (in Lactobacillus plantarum), pncA
(in Streptococcus pyogenes, Streptococcus equi, and Clostridium
tetani), and/or the RNam salvage transporter pnuC (in S.
pneumoniae and Streptococcus mutans) (Rodionov et al., 2008a)
is less common. Moreover, the NiaR regulon contains membrane
proteins that putatively have a role in niacin uptake. The most
abundant NiaP family is found in ten NiaR-containing species
(Bacilli, Lactobacilli and Thermotogales) in addition to several
species that do not have the NiaR regulator (Rodionov et al.,
2008a). Among Streptococci and Clostridia, NiaX is found in
twelve genomes, and NiaY is found in five genomes (Bacilli
and Clostridia). Several lines of genomic evidence support the
putative involvement of these gene families in niacin uptake
including the predicted co-regulation with NAD biosynthesis
and niacin salvage genes, and co-occurrence with the niacin
salvage genes pncB-pncA (Rodionov et al., 2008a). Our study
demonstrates that niaX, pnuC, and nadC are the genes that have
a putative NiaR operator site in their promoter regions and are
repressed by NiaR in the presence of niacin. We have further
confirmed the NiaR operator sites in the promoter regions of
niaX, pnuC, and nadC by mutagenesis studies. There are some
other genes that are differentially expressed under our tested
conditions (fba, rex, gapN, pncB-nadE, gap, spd-1824, spd-1827,
adhE, and adhB2). The change in the expression of these genes
suggests that these genes may have a role in the transport and
biosynthesis of niacin or they may be upregulated due to some
indirect effect of niacin genes. These genes do not have a putative
NiaR operator site in their promoter regions suggesting the
role of another transcriptional regulator in the regulation of
fba, rex, gapN, pncB-nadE, gap, spd-1824, spd-1827, adhE, and
adhB2. Therefore, we propose that the study of the regulatory
mode of the above-mentioned genes would shed light on this
possibility.
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